BT-001, an oncolytic vaccinia virus armed with a Treg-depleting human recombinant anti-CTLA4 antibody and GM-CSF to target the tumor microenvironment

Poster BT-001
M. Semmrich et al.
SITC 2020
Download the abstract here
Poster Presentation